IRCT201105296626N1
Completed
未知
Study on compare of sublingual, rectal and vaginal misoprostol for cervical priming 12 hours before hysteroscopy
Tabriz University of medical science0 sites120 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Condition 1: Patients who are candidates for hysteroscopy. Condition 2: Patients who are candidates for hysteroscopy.
- Sponsor
- Tabriz University of medical science
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All the patients who need diagnostic hysteroscopy and surgery such as: irregular uteral bleeding; inter uteral lesions in hysterosalpangography or sonography.
- •Exclusion criteria: pregnancy; urinary tract infection; history of previous cervix surgery; cervix failure; patient dissatisfaction and prohibition prostaglandin intake
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Safety And Efficacy Sublingual Misoprostol Versus Vaginal Misoprostol.PACTR202310744034060Dr. Aituma Lewis Osadebamwen82
Recruiting
Not Applicable
A study to compare vaginal and sublingual routes of misoprostol following mifepristone for second trimester(13-20 weeks period of gestation) abortionsHealth Condition 1: O048- (Induced) termination of pregnancywith other and unspecified complicationsCTRI/2020/04/024818PGIMER
Completed
Not Applicable
Misoprostol in therapeutic abortioTherapeutic abortion.Therapeutic AbortionIRCT2013040912958N1Tehran University of Medical Sciences480
Recruiting
Phase 2
Comparison of the effect of vaginal versus sublingual misoprostol in medical induction of missed abortionsMissed abortion.Missed abortionIRCT201704179014N159Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences100
Not yet recruiting
Phase 3
Comparison between misoprostol pushed rectally and given below tongue before cesarean section to control blood loss during and after the surgery.Health Condition 1: O721- Other immediate postpartum hemorrhageHealth Condition 2: O720- Third-stage hemorrhageCTRI/2020/11/029043IPGMER